| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Cahn J, Herold M, Dubrasq... |
Contribution a un concept biochimique des psychoses experimentales. VI... |
C.R.Soc.Biol. |
1958 |
| Van den Driessche J, Alla... |
Antagonisme de la 1 [2-(5, 6 diméthyl-3 indolyl) éthyl-4 phényl-pipéra... |
C.R. Soc. Biol. |
1968 |
| Leonard BE, Liska KJ |
Effects of morpholino-, pyrrolidino-, piperazine-, and cyclo-octyle-de... |
Life Sci |
1971 |
| Campbell H, Cline W, Evan... |
Comparison of the effects of dexamphetamine and 1-benzylpiperazine in ... |
Eur J Clin Pharmacol |
1973 |
| Bye C, Munro-Faure AD, Pe... |
A comparison of the effects of 1-benzylpiperazine and dexamphetamine o... |
Eur J Clin Pharmacol |
1973 |
| Samanin R, Mennini T, Fer... |
m-Chlorophenylpiperazine: A Central Serotonin Agonist Causing Powerful... |
Naunyn-Schmiedeberg'... |
1979 |
| Luscombe G, Jenner P, Mar... |
Myoclonus In Guinea Pigs Is Induced By Indole-containing But Not Piper... |
Life Sciences |
1982 |
| Cohen ML, Fuller RW |
Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine... |
Life Sci |
1983 |
| Aloi JA, Insel TR, Muelle... |
Neuroendocrine and Behavioral Effects of m-Chlorophenylpiperazine Admi... |
Life Sciences |
1984 |
| Luscombe G, Jenner P, Mar... |
Correlation Of [3h]5-hydroxytryptamine (5ht) Binding To Brain Stem Pre... |
European Journal of ... |
1984 |
| Erspamer V, Melchiorri P,... |
Phyllomedusa skin: a huge factory and store-house of a variety of acti... |
Peptides |
1985 |
| Cascio G, Manghisi E, Por... |
N-phenylpiperazine derivatives with hypocholesterolemic activity |
J Med Chem |
1985 |
| Grome JJ, Harper AM |
Local Cerebral Glucose Utilisation Following Indoleamine- and Piperazi... |
Journal of Neurochem... |
1986 |
| Ransom RW, Asarch KB, Shi... |
[3H] 1-[2-(4-Aminophenyl)Ethyl]-4-(3-Trifluoromethylphenyl)Piperazine:... |
Journal of Neurochem... |
1986 |
| McKenney JD, Glennon RA |
TFMPP May Produce its Stimulus Effects Via a 5-HT1B Mechanism |
Pharmacology Biochem... |
1986 |
| Charney DS, Woods SW, Goo... |
Serotonin function in anxiety II. Effects of the serotonin agonist MCP... |
Psychopharmacology B... |
1987 |
| Aulakh CS, Cohen RM, Hill... |
Long-term imipramine treatment enhances locomotor and food intake supp... |
Br J Pharmacol |
1987 |
| Charney DS, Goodman WK, P... |
Serotonin function in obsessive-compulsive disorder A comparison of th... |
Arch Gen Psychiatry |
1988 |
| Schechter MD |
Use of TFMPP stimulus properties as a model of 5-HT1B receptor activat... |
Pharmacol Biochem Be... |
1988 |
| Frances H |
Psychopharmacological profile of 1-(m-(trifluoromethyl) phenyl) pipera... |
Pharmacol Biochem Be... |
1988 |
| Britt SG, Gonias SL, Sand... |
Agonist and antagonist activities of arylpiperazines at human platelet... |
J Pharmacol Exp Ther |
1988 |
| Arnt J, Hyttel J |
Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2... |
Eur J Pharmacol |
1989 |
| Klodzinska A, Jaros T, Ch... |
Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine ... |
J Neural Transm Park... |
1989 |
| Kahn RS, Wetzler S, Asnis... |
Effects of m-chlorophenylpiperazine in normal subjects: a dose-respons... |
Psychopharmacology (... |
1990 |
| Winslow JT, Insel TR |
Serotonergic modulation of rat pup ultrasonic vocal development: studi... |
J Pharmacol Exp Ther |
1990 |
| Frambes NA, Kirstein CL, ... |
5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential behavio... |
Eur J Pharmacol |
1990 |
| Chaouloff F, Laude D, Bau... |
Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5... |
Eur J Pharmacol |
1990 |
| Winslow JT, Insel TR |
Serotonergic modulation of the rat pup ultrasonic isolation call: stud... |
Psychopharmacology (... |
1991 |
| Boja JW, Schechter MD |
Possible serotonergic and dopaminergic mediation of the N-ethyl-3,4-me... |
Eur J Pharmacol |
1991 |
| Chaouloff F, Baudrie V, L... |
The 5-HT2 receptor agonist 1-2,5-dimethoxy-4-iodophenyl2-aminopropane ... |
Eur J Pharmacol |
1992 |
| Hashimoto K, Maeda H, Gor... |
Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-me... |
Brain Res |
1992 |
| Hashimoto K, Maeda H, Gor... |
Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity ... |
Eur J Pharmacol |
1992 |
| Herndon JL, Pierson ME, G... |
Mechanistic investigation of the stimulus properties of 1-(3-trifluoro... |
Pharmacol Biochem Be... |
1992 |
| Aulakh CS, Hill JL, Yoney... |
Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food int... |
Psychopharmacology (... |
1992 |
| Germine M, Goddard AW, Wo... |
Anger and anxiety responses to m-chlorophenylpiperazine in generalized... |
Biol Psychiatry |
1992 |
| Hashimoto K |
Effects of benzylpiperazine derivatives on the acute effects of 3,4-me... |
Neurosci Lett |
1993 |
| Hashimoto K, Maeda H, Hir... |
Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine ... |
Eur J Pharmacol |
1993 |
| Schechter MD, Gordon TL |
Comparison of the behavioral effects of ibogaine from three sources: m... |
Eur J Pharmacol |
1993 |
| Chaouche-Teyara K, Fourni... |
Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated... |
Eur J Pharmacol |
1993 |
| Aulakh CS, Mazzola-Pomiet... |
Evidence that 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane-induced ... |
J Pharmacol Exp Ther |
1994 |
| Aulakh CS, Mazzola-Pomiet... |
Lack of cross-tolerance for hypophagia induced by DOI versus m-CPP sug... |
Neuropsychopharmacol... |
1995 |
| Benjamin J, Greenberg BD,... |
Daily administration of m-chlorophenylpiperazine to healthy human volu... |
Psychopharmacology B... |
1996 |
| Buydens-Branchey L, Branc... |
Hormonal, psychological, and alcohol craving changes after m-chlorophe... |
Alcohol Clin Exp Res |
1997 |
| Rotzinger S, Fang J, Bake... |
Trazodone is metabolized to m-chlorophenylpiperazine by CYP3A4 from hu... |
Drug Metab Dispos |
1998 |
| McCann UD, Eligulashvili ... |
Altered neuroendocrine and behavioral responses to m-chlorophenylpiper... |
Psychopharmacology (... |
1999 |
| Leone M, Attanasio A, Cro... |
The serotonergic agent m-chlorophenylpiperazine induces migraine attac... |
Neurology |
2000 |
| Balmelli C, Kupferschmidt... |
Fatal brain edema after ingestion of ecstasy and benzylpiperazine |
Dtsch Med Wochenschr |
2001 |
| Baumann MH, Ayestas MA, D... |
1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin rele... |
Neuropsychopharmacol... |
2001 |
| Tancer, ME, Johanson, C-E |
The subjective effects of MDMA and mCPP in moderate MDMA users |
Drug and Alcohol Dep... |
2001 |
| de Boer D, Bosman IJ, Hid... |
Piperazine-like compounds: a new group of designer drugs-of-abuse on t... |
Forensic Sci Int |
2001 |
| Hatzidimitriou G, Tsai EH... |
Altered prolactin response to M-chlorophenylpiperazine in monkeys prev... |
Synapse |
2002 |
| Rothman R, Baumann M |
Therapeutic and adverse actions of serotonin transporter substrates |
Pharmacol Ther |
2002 |
| Gobbi M, Moia M, Pirona L... |
p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neur... |
J Neurochem |
2002 |
| Gijsman HJ, Van Gerven JM... |
Saccadic peak velocity and EEG as end-points for a serotonergic challe... |
Hum Psychopharmacol |
2002 |
| Taffe MA, Davis SA, Yuan ... |
Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to s... |
Neuropsychopharmacol... |
2002 |
| Bull EJ, Hutson PH, Fone ... |
Reduced social interaction following 3,4-methylenedioxymethamphetamine... |
Neuropharmacology |
2003 |
| Peters FT, Schaefer S, St... |
Screening for and validated quantification of amphetamines and of amph... |
J Mass Spectrom |
2003 |
| Taffe MA, Huitron-Resendi... |
MDMA exposure alters cognitive and electrophysiological sensitivity to... |
Pharmacol Biochem Be... |
2003 |
| Staack RF, Fritschi G, Ma... |
New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas ... |
J Mass Spectrom |
2003 |
| Tancer M, Johanson CE |
Reinforcing, subjective, and physiological effects of MDMA in humans: ... |
Drug Alcohol Depend |
2003 |
| Staack RF, Theobald DS, P... |
In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperaz... |
Xenobiotica |
2004 |
| Maurer HH, Kraemer T, Spr... |
Chemistry, pharmacology, toxicology, and hepatic metabolism of designe... |
Ther Drug Monit |
2004 |
| Feuchtl A, Bagli M, Steph... |
Pharmacokinetics of m-chlorophenylpiperazine after intravenous and ora... |
Pharmacopsychiatry |
2004 |
| Austin H, Monasterio E |
Acute psychosis following ingestion of 'Rapture' |
Australas Psychiatry |
2004 |
| Fantegrossi WE, Winger G,... |
Reinforcing and discriminative stimulus effects of 1-benzylpiperazine ... |
Drug Alcohol Depend |
2005 |
| Baumann MH, Clark RD, Bud... |
N-substituted piperazines abused by humans mimic the molecular mechani... |
Neuropsychopharmacol... |
2005 |
| Staack RF, Maurer HH |
Metabolism of designer drugs of abuse |
Curr Drug Metab |
2005 |
| Bossong MG, Van Dijk JP, ... |
Methylone and mCPP, two new drugs of abuse? |
Addict Biol |
2005 |
| Johanson CE, Kilbey M, Ga... |
Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (... |
Drug Alcohol Depend |
2006 |
| Russell B |
Party pills - how little is known? |
New Zealand Family P... |
2006 |
| Sheridan J, Butler R, Wil... |
Legal piperazine-containing party pills--a new trend in substance misu... |
Drug Alcohol Rev |
2007 |
| Kikura-Hanajiri R, Kawamu... |
Analytical data of designated substances (Shitei-Yakubutsu) controlled... |
Yakugaku Zasshi |
2008 |
| Pichini S, Pujadas M, Mar... |
Liquid chromatography-atmospheric pressure ionization electrospray mas... |
J Pharm Biomed Anal |
2008 |
| Uchiyama N, Kikura-Hanaji... |
[Analysis of designer drugs detected in the products purchased in fisc... |
Yakugaku Zasshi |
2008 |
| Wood DM, Button J, Lidder... |
Dissociative and sympathomimetic toxicity associated with recreational... |
J Med Toxicol |
2008 |
| Nutt DJ |
Equasy-- an overlooked addiction with implications for the current deb... |
J Psychopharmacol |
2009 |
| Westphal F, Junge T, Girr... |
Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-... |
Forensic Sci Int |
2009 |
| Vogels N, Brunt TM, Rigte... |
Content of ecstasy in the Netherlands: 1993-2008 |
Addiction |
2009 |
| Uchiyama N, Miyazawa N, K... |
[Analysis of newly distributed designer drugs detected in the products... |
Yakugaku Zasshi |
2010 |
| Wohlfarth A, Weinmann W |
Bioanalysis of new designer drugs |
|
2010 |
| Wood DM, Greene SL, Darga... |
Clinical pattern of toxicity associated with the novel synthetic cathi... |
Emerg Med J |
2010 |
| Davies S, Wood DM, Smith ... |
Purchasing 'legal highs' on the Internet--is there consistency in what... |
QJM |
2010 |
| Bossong MG, Brunt TM, Van... |
mCPP: an undesired addition to the ecstasy market |
J Psychopharmacol |
2010 |
| Lin JC, Jan RK, Lee H, Je... |
Determining the subjective and physiological effects of BZP combined w... |
Psychopharmacology B... |
2010 |
| Min JZ, Yamashita K, Toyo... |
Simultaneous and group determination methods for designated substances... |
Biomed Chromatogr |
2010 |
| Kikura-Hanajiri R, Uchiya... |
Survey of current trends in the abuse of psychotropic substances and p... |
Leg Med Tokyo |
2011 |
| Kerr JR, Davisi LS |
Benzylpiperazine in New Zealand: brief history and current implication... |
J Roy Soc New Zeal |
2011 |
| Maskell PD, De Paoli G, S... |
Mephedrone (4-methylmethcathinone)-related deaths |
J Anal Toxicol |
2011 |
| Baron M, Elie M, Elie L |
An analysis of legal highs-do they contain what it says on the tin? |
Drug Test Anal |
2011 |
| Elliott S |
Current awareness of piperazines: pharmacology and toxicology |
Drug Test Anal |
2011 |
| Bassindale T |
Benzylpiperazine: the New Zealand legal perspective |
Drug Test Anal |
2011 |
| Hill SL, Thomas SH |
Clinical toxicology of newer recreational drugs |
Clin Toxicol (Phila) |
2011 |
| Brunt TM, Koeter MW, Nies... |
Linking the pharmacological content of ecstasy tablets to the subjecti... |
Psychopharmacology (... |
2011 |
| Arbo MD, Bastos ML, Carmo... |
Piperazine compounds as drugs of abuse |
Drug Alcohol Depend |
2011 |
| Rosenbaum CD, Carreiro SP... |
Here Today, Gone Tomorrow...and Back Again? A Review of Herbal Marijua... |
J Med Toxicol |
2012 |
| Nelson ME, Bryant SM, Aks... |
Emerging drugs of abuse |
Emerg Med Clin North... |
2014 |
| Cuypers E, Bonneure AJ, T... |
The use of presumptive color tests for new psychoactive substances |
Drug Testing and Ana... |
2014 |
| Helander A, Bäckberg M, B... |
MT-45, a new psychoactive substance associated with hearing loss and u... |
Clin Toxicol (Phila) |
2014 |
| Schifano F, Orsolini L, D... |
Novel psychoactive substances of interest for psychiatry |
World Psychiatry |
2015 |
| Adamowicz P, Gieron J, Gi... |
The prevalence of new psychoactive substances in biological material -... |
Drug Test Anal |
2015 |
